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Measurement properties of step 
tests for exercise capacity in  
COPD: A systematic review
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Abstract
Objective: To determine the level of evidence of the measurement properties (validity, reliability, 
and responsiveness) and interpretability of the step tests available for assessing the exercise capacity in 
patients with chronic obstructive pulmonary disease.
Data sources: The data sources Web of Science, MEDLINE, PubMed, PEDro, CENTRAL of Cochrane 
Library, and Scopus were searched up to June 26, 2020.
Review methods: Studies of any design that reported results for any measurement property of the 
step tests for assessing the exercise capacity in COPD patients were selected. One reviewer extracted 
the data, and two reviewers independently rated the level of evidence by using the Consensus-Based 
Standards for the Selection of Health Measurements Instruments recommendations.
Results: Thirty-one studies were included in the data synthesis. Chester Step Test, Modified Incremental 
Step Test, two-, three-, four-, and six-Minute Step Test, Paced Step Test, and six-Minute Stepper Test 
were identified. A step test protocol was also found. The level of evidence of their results for the 
measurement properties was mostly determined as “low” to “very low.” The best level of evidence 
found was for the six-minute stepper test: “high” on construct validity (r = 0.56–0.71); and “moderate” on 
criterion validity (r = 0.36–0.69), and responsiveness (r = 0.26–0.34).
Conclusion: The general level of evidence of the measurement properties of the step tests is “low” 
to “very low” for assessing exercise capacity in patients with chronic obstructive pulmonary disease, 
which can limit their application in clinical practice. The six-minute Stepper Test is currently the most 
appropriate step test available.
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Introduction
The assessment of exercise capacity is an important 
clinical measure of the functional status in people 
with chronic obstructive pulmonary disease.1 It is 
defined as one’s physiological maximal response to 
exercise, including the exercise tolerance tests, or 
the body structure’s maximal ability to fulfill its 
function, including the measurement of maximal 
muscle contractions.2 The gold standard tests used 
for its assessment are the cardiopulmonary exercise 
testing, on a treadmill or a cycloergometer,3 and the 
one-repetition maximum.4 Additionally, in pulmo-
nary rehabilitation, the field walking tests are also 
considered valid options, especially the six-minute 
walk test and the incremental or endurance shuttle 
walk test.2,5
However, these mentioned tests require a large 
amount of space, aside from the expensive equip-
ment for the cardiopulmonary exercise testing,3,5 
which may limit their application in the new mod-
els of pulmonary rehabilitation suggested in the 
literature, like the community- and home-based 
programs.6 These new models are important strat-
egies to enhance population access to pulmonary 
rehabilitation services, from the moment that their 
benefits are already comparable to those obtained 
with the hospital-based.7,8 Also, as a result of this 
time of COVID-19 pandemic, the transition of 
the hospital services to community and home is 
necessary,9 and, for that, the search for tests with 
minimal space requirements for exercise testing is 
necessary.
The step testing could be a promising tool, as it 
requires less physical space, the equipment is feasi-
ble, and it is representative of the daily activities 
(stair climbing). A wide variety of step tests have 
been described not only with different equipment, 
such as the use of a step or a stepper,10 but also with 
different aims, according to the self-paced, con-
stant, or externally paced work rate. In a recent 
review, to identify exercise tests that are suitable 
outside the traditional hospital-based pulmonary 
rehabilitation programs, step testing was consid-
ered a useful resource in people with chronic res-
piratory diseases.9
In chronic obstructive pulmonary disease, the 
identification of the measurement properties and 
the interpretability of step testing have been ana-
lyzed in the last years,11,12 however, it is important 
to assess the quality of the current level of evidence 
of the measurement properties before the full imple-
mentation of the step testing in clinical practice. 
Therefore, this study aimed to determine the level 
of evidence of the measurement properties (valid-
ity, reliability, and responsiveness) and interpreta-
bility of the step tests available for assessing the 
exercise capacity in people with chronic obstructive 
pulmonary disease.
Methods
This systematic review was conducted in accord-
ance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses guidelines 
(PRISMA),13 and was registered in the International 
Prospective Register of Systematic Reviews 
(PROSPERO) (CRD42020155872).
The literature search was conducted in the fol-
lowing electronic databases: Web of Science, 
MEDLINE, PubMed, Physiotherapy Evidence-
Based Database, Cochrane Central Register of 
Controlled Trials, and Scopus. The search was per-
formed between 21st and 26th of June 2020. The 
key terms used were “step test,” “stepper test,” 
“stepping,” “COPD,” and “chronic obstructive pul-
monary disease.” The search strategy is available 
in Supplemental Appendix 1.
For this review, a step test was defined as a test 
where people are instructed to step up and down on 
a platform (step or stepper) with a specific height, 
and in a self-paced and/or externally paced work 
rate. Studies of any design that reported results for 
any measurement property (validity, reliability, 
responsiveness), and interpretability of the step 
tests for assessing the exercise capacity in people 
with chronic obstructive pulmonary disease were 
selected. For this review, we assumed the identifi-
cation of the step tests that provided the maximum 
amount of physical exertion that a patient can sus-
tain according to the aim of each test. Another 
important inclusion criterion was the diagnosis of 
the chronic obstructive pulmonary disease based 
on the Global Initiative for Chronic Obstructive 
Lung Disease criteria.14 Studies not written in 
English or Portuguese, published in non-indexed 
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journals and abstracts in conference proceedings 
were excluded. One reviewer (R.V.) performed the 
initial screening of the articles based on type of 
publication and relevance for the review. Then, the 
full-text of each relevant study was screened for 
content to decide its eligibility. Selection of studies 
was checked by a second reviewer (A.M.M.).
Data extraction focused on the measurement 
properties (validity, reliability, and responsive-
ness) and interpretability defined according to the 
Consensus-Based Standards for the Selection of 
Health Measurements Instruments (COSMIN) def-
initions (Supplemental Appendix 2).15–17 For crite-
rion validity, we assumed the comparisons of the 
step tests with the cardiopulmonary exercise test-
ing and the one-repetition maximum, considered 
the gold standard measures for exercise capacity.2 
For construct validity, we considered the compari-
sons with the six-minute walking test, incremental 
shuttle walk test, endurance shuttle walk test, and 
other tests available to assess muscle strength. For 
reliability, studies of test-retest reliability or of 
measurement error were considered. On the other 
hand, for responsiveness, we considered the stud-
ies that used the step tests to analyze the effects of 
any intervention, with changes over time and 
through comparisons with changes in other out-
comes. The interpretability was included accord-
ing to the qualitative meaning of the tests, for 
example, with norm scores and minimal impor-
tant difference.18 According to Schunemann et al., 
minimal important difference provides the small-
est change in the outcome of interest that patients 
perceive as important, either beneficial or harmful, 
and that would lead the patient or clinician to con-
sider a change in management.19
The methodological quality of the studies 
included was assessed by the Consensus-Based 
Standards for the Selection of Health Measurements 
Instruments risk-of-bias checklist (box 6, 7, 8, 9, 
and 10), based on a rating score system of four-
point rating scale (“very good,” “adequate,” 
“doubtful” or “inadequate”).15 For each study, the 
score per box is obtained by taking the lowest rat-
ing of any item in a box. According to the recom-
mendations by Terwee et al.,20 we assumed for the 
reliability and measurement error studies, that the 
step tests conducted on the same day were not 
appropriate (item 2 of box 6 and 7). Furthermore, 
the studies on responsiveness that used only the 
paired sample T-test or Wilcoxon signed-rank test 
to measure significant changes were also not 
appropriated (item 6, 9, and 12 of box 10).21
Another rating was performed for the quality of 
the measurement properties using the rating system 
proposed by Terwee et al.,22 where one or more cri-
teria was used to define a “sufficient” (+), “inde-
terminate” (?) or “insufficient” (−) rating depending 
on the designs, methods, and outcomes of the 
studies. The definition and criteria for each meas-
urement property are described in Supplemental 
Appendix 2.
After rating the methodological and measure-
ment properties qualities, the modified Grading of 
Recommendations Assessment, Development, and 
Evaluation (GRADE) approach was applied to 
grade the level of evidence, as “high,” “moderate,” 
“low,” or “very low.”15 The level of evidence was 
based in four factors: risk of bias, inconsistency, 
imprecision, and indirectness.15
For all ratings, each study was reviewed and 
assessed by two independent investigators (R.V. 
and A.M.M.) and discordances in scoring between 
the two reviewers were resolved by consensus. 
Some studies were analyzed in more than one 
measurement property and, in this case, the quality 
assessment and data extraction of each property 
were made separately.
Consensus-Based Standards for the Selection of 
Health Measurements Instruments has no scoring 
system for interpretability.
Descriptive synthesis of the types and the char-
acteristics of the step tests identified was conducted. 
Besides, in each study, the name of the authors, 
country, the published year, measurement proper-
ties assessed, sample characteristics (number of 
participants and age), study aims, and the outcomes 
measures were retrieved. To determine each meas-
urement property on each step test identified, we 
also summarized its quality and level of evidence.
Results
The literature search provided a total of 856 records. 
After duplicates were removed, 637 records were 
screened for content through title and abstract. 
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From these, 561 were excluded. The full-text of 76 
articles was assessed for eligibility and 45 articles 
were excluded. In total, 31 articles were included 
(Figure 1) all published in English. The studies 
were conducted in South America – Brazil (n = 11), 
North America – Canada (n = 3), and Europe – 
France (n = 14), Ireland (n = 1), the Netherlands 
(n = 1), and United Kingdom (n = 1). The flowchart 
of the study is presented in Figure 1.
The tests identified were the Chester Step Test,23 
Modified Incremental Step Test,24 two-minute Step 
Test,25 three-minute Step Test,26 four-minute Step 
Test,27 six-minute Step Test,28 Paced Step Test,29 
and six-minute Stepper test.10 A Step Test Protocol 
was also included.30 The characteristics of the tests 
are available in Table 1.
Eleven articles included validity,29,31–40 seven 
articles included reliability,30,31,33,35,41–43 13 articles 
included responsiveness,36,37,43–53 and five articles 
included interpretability33,34,37,54,55 of the step tests. 
Details on each article included in this review are 
presented in Supplemental Appendix 3.
For each step test identified, the summary result 
of the measurement properties and the overall level 
of evidence, according to the modified Grading of 
Recommendations Assessment, Development, and 
Evaluation approach, are presented in Table 2.
Criterion validity was evaluated for the 
Chester Step Test,31 Modified Incremental Step 
Test,33 Paced Step Test,29 and six-minute Stepper 
Test36,38,39 by comparison with the cardiopulmo-
nary exercise testing. The six-minute Stepper Test 
also presented a comparison with the quadriceps 
one-repetition maximum.40 Construct validity was 
evaluated for the Chester Step Test,31,32 three-min-
ute Step Test,35 six-minute Step Test,34 and six-
minute Stepper Test36,37,39 by comparison with the 
six-minute walk test. The Chester Step Test also 
presented a comparison with the Incremental shut-
tle walk test.32
On reliability, the Modified Incremental Step 
Test and the Step Test Protocol were the only tests 
with an appropriate time interval,30,33 with tests 
conducted on different days.
Figure 1. Flowchart of the study.
COPD: chronic obstructive pulmonary disease; GOLD: global initiative for chronic obstructive lung diseases.
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Responsiveness for the step tests was evaluated 
in patients undergoing pulmonary rehabilitation 
(six-minute Step Test,46 and six-minute Stepper 
Test),36,37,43,50,52,56–59 physical training program (three-
minute Step Test,48 and six-minute Step Test45,47), 
pharmacological treatment – bronchodilator (three-
minute Step Test49), physical activity counseling 
program (two-minute Step Test),44 and photobio-
modulation therapy (six-minute Stepper Test51). 
However, only the six-minute Stepper Test presented 
appropriate statistical analysis in two articles,36,37 
according to the correlations between the changes in 
the number of steps and changes in the six-minute 
walk test (distance) in pulmonary rehabilitation.
The data available on the interpretability of the 
step tests are presented in Table 3.
The methodological quality of each article, and 
the quality of each measurement property included 
in this review are presented in Supplemental 
Appendix 4.
Discussion
This systematic review identified nine step tests and 
showed that the level of evidence of their measure-
ment properties for assessing the exercise capacity in 
people with chronic obstructive pulmonary disease is 
mostly “low” and “very low.” According to the mod-
ified Grading of Recommendations Assessment, 
Development, and Evaluation approach, the main 
reasons for these ratings were based in the small 
samples of participants included in the articles, and 
the presence of one or multiple articles of “inade-
quate” methodological quality.15 However, despite 
our great effort to rate the methodological quality 
of the articles, we cannot assume these results as an 
absolute result, considering that we included stud-
ies that reported results for the measurement prop-
erties of the tests even if they were not specifically 
designed for it.
In general, reliability and responsiveness were 
the measurement properties with the worst level 




Stages Initial work 
rate
Increments Duration Profile Original reference
CST 5 stages 15 steps/min 5 steps/min 
(every 2 min)
10 min Incremental Sykes et al.23
MIST – 10 steps/min 1 step/min 
(every 30 sec)
Up to the limit 
of tolerance
Incremental de Andrade et al.24
2MST – Free work rate (targeting the 
maximum number of steps)
2 min Self-paced Rikli et al.25
3MST – Free work rate or externally 
paced stepping rates (targeting 
the maximum number of steps)
3 min Self-paced 
or constant
YMCA26
4MST – Free work rate (targeting the 
maximum number of steps)
4 min Self-paced Stephan et al.27
6MST – Free work rate (targeting the 
maximum number of steps)
6 min Self-paced Dal Corso et al.28
Paced step 
test





4 stages 4 stages of three-minute  
(18, 22, 26, and 32 steps/min)
12 min Constant Perrault et al.30
6MSpT – Free work rate (targeting the 
maximum number of steps)
6 min Self-paced Borel et al.10
CST: Chester step test; MIST: modified incremental step test; 2MST: two-minute step test; 3MST: three-minute step test;  
4MST: four-minute step test; 6MST: six-minute step test; 6MSpT: six-minute stepper test.
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of evidence, where most of the step tests pre-
sented “very low” rating, explained by the test-
retest studies performed on the same day, the 
non-determination of the minimal important dif-
ferences for measurement error, and only the use 
of the paired sample T-test or Wilcoxon signed-
rank test for responsiveness.15,21
Another finding in our review was the heteroge-
neity found on the evidence available for the step 
tests, where some tests showed fewer results in iso-
lated articles (Modified Incremental Step Test, 
two-minute Step Test, four-minute Step Test, Paced 
Step Test, and Step Test Protocol), which repre-
sents a weakness to determine their measurement 
properties. This poor quality of evidence reflects 
the lack of application of this type of exercise test-
ing in evidence, and, consequently, in clinical prac-
tice, especially in the new models of pulmonary 
rehabilitation. Despite the proven benefits of the 
community- and home-based programs, the assess-
ment of their results in exercise capacity outcome 
is still widely performed in a hospital or clinical 
setting, mostly with the field walking tests.7,8 Given 
the example of the six-minute Stepper Test, this 
test gathers results for all the measurement proper-
ties and presents the best ratings for the level of 
evidence due to its large implementation not only 
in hospital settings36,37,43 but also in home-based 
programs, where the assessment of its results was 
performed in the people’ homes.52 In fact, the 
“moderate” to “high” level of validity of the six-
minute Stepper Test is reflected by the good cor-
relations found with cardiopulmonary exercise 
testing, one-repetition maximum and the six-minute 
walk test, proven that this test can be an alternative 
to assess exercise capacity in people with chronic 
obstructive pulmonary disease. The same test was 
also rated as “moderate” responsiveness to pulmo-
nary rehabilitation, due to the overall rating of the 
measurement property determined as “insufficient” 
(r = 0.26–0.34). This finding suggests a low corre-
lation between the changes of the six-minute 
Stepper Test and the changes in the six-minute 
walk test, but one recommendation should be high-
lighted. The inclusion of the stepping as a type 
(mode) of exercise training could be an interesting 
option in endurance training, since the physiologic 
adaptations to exercise are specific to the type of 
exercise performed.60 Thus, further studies on 
responsiveness should include this type of exercise 
training.
Another good rating was the “moderate” level 
of evidence on the construct validity of the three-
Minute Step Test, due to its strong correlation with 
the six-minute walk test. In fact, despite the “low” 
ratings of level of evidence, other step tests that 
were compared with six-minute walk test (Chester 
Step Test, six-minute Step Test) also presented a 
consistent strong correlation. These correlations 
were mostly analyzed with performance variables 
of the tests (number of steps and six-minute walk 
distance), which support the conceptualization of 
these step tests as an important option to assess 
functional exercise performance.61 This finding is 
supported by the fact that the measurement prop-
erties of the six-minute walk test qualify it as a 
more targeted test to assess functional exercise 
performance.2,61 In fact, according to the step tests 
identified and their type of performance (self-
paced, incremental, and/or constant work rate), we 
can assume that the different aims between the tests 
can reflect the assessment of different outcomes. 
Table 3. Interpretability of the step tests.
Test Interpretability
MIST33 VO2 (L) = –221.576 + [4.833 × number of steps] + [12.019 × body mass (kg)]
3MST55 VO2 (L/min) = [0.015286 × body mass (kg)] + [0.035605 × step rate (steps/min)]–0.698449
4MST54 Cut-off of 65 steps, where higher values provide better prognostic, with mortality being 
significantly lower.
6MST34 Cut-off of 86 steps, where people with similar or lower values can be classified as low 
physical capacity.
6MSpT37 A MID of 20 steps (intervention: pulmonary rehabilitation).
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Given the example of the six- and three-minute 
Step Tests, these ones are clearly stepping versions 
of the six-minute walking test, which they could 
provide more results about functional exercise per-
formance. On the other hand, the step tests with an 
incremental profile (Chester Step Test and Modified 
Incremental Step Test), given the similarity of the 
aims with the shuttle walk test, could be also con-
sidered a symptom-limited maximal exercise 
capacity tests. However, the results in this review 
cannot fulfill these statements. Future research is 
recommended for the development of studies on 
validity of the step tests including cardiorespira-
tory response and the comparison with the gold 
standard tests for exercise capacity, and other phys-
iological variables.
To the best of our knowledge, there is no review 
available in evidence that determined the level of 
evidence of the measurement properties of step test-
ing in chronic respiratory diseases. Even so, the 
application of step testing has also been applied in 
other chronic respiratory diseases, with promising 
results, especially on validity. As an example, the 
Modified Incremental Test, Chester Step Test, 
three- and six-minute Step Test present good cor-
relations mostly with the field walking tests in 
people with Bronchiectasis,62,63 Interstitial Lung 
Disease,28 and Asthma.64 This is also the first sys-
tematic review that includes step tests using differ-
ent equipment (step and stepper). Another strength 
of this review is the inclusion of studies that reported 
measurement properties of the test even if they 
were not specifically designed for it, which allowed 
us to identify a broad range of studies.
There were some study limitations. First, this 
systematic review only included articles written 
in English and Portuguese, which led to the exclu-
sion of relevant studies. Second, during the litera-
ture search we found abstracts in congresses with 
potential measurement properties for step and 
stepper tests, but according to exclusion criteria 
these studies were not included. Another limita-
tion refers to the involvement of one reviewer in 
the initial screening of articles, although two 
reviewers worked in close collaboration with sev-
eral meetings throughout the selection process.
Future research is important to improve the level 
of evidence of the step tests, where future studies 
should be conducted following the recommenda-
tions of the Consensus-Based Standards for the 
Selection of Health Measurements Instruments to 
develop appropriate results.
In conclusion, the general level of evidence of 
the measurement properties of the step tests identi-
fied is “low” to “very low” for assessing exercise 
capacity in people with chronic obstructive pul-
monary disease, which can limit their current 
application in clinical practice. On the available 
evidence, the six-minute Stepper Test is currently 
the most appropriate step test available. Future 
well-designed studies are necessary to improve the 
quality of the measurement properties of the step 
tests.
Clinical Messages
•• The current level of evidence of the meas-
urement properties of the step tests is 
“low” to “very low” for assessing exercise 
capacity in people with chronic obstruc-
tive pulmonary disease.
•• Robust methods should be designed and 
implemented to get a higher quality of the 
measurement properties of the step tests.
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